Table 1 Baseline characteristics of 203 patients treated for squamous cell carcinoma of the esophagus.
From: Expense and benefit of neoadjuvant treatment in squamous cell carcinoma of the esophagus
Surgery alone (n = 170) | NT + Surgery (n = 33) | p-Value | |
|---|---|---|---|
Sex | |||
- male | 133 (78) | 25 (76) | 0.8102 |
- female | 37 (22) | 8 (24) | |
Age (years) | 57.2 | 54.5 | 0.0714 |
Observation (years) | 8.0 | 5.7 | 0.001 |
Tumor site | |||
- upper / middle third | 110 (65) | 31 (94) | 0.0004 |
- lower third | 60 (35) | 2 (6) | |
Type of resection | |||
- transthoracic | 112 (66) | 26 (79) | 0.16 |
- transhiatal | 58 (34) | 7 (21) | |
Type of reconstruction | |||
- gastric tube | 161 (95) | 33 (100) | 0.3601 |
- colonic interposition | 9 (5) | 0 |